Scientific progress in ACLF to be featured at The Liver Meeting® 2024, with 4 posters presenting new preclinical data ... Data readout from 4 clinical trials anticipated by the end of 2025 Building on ...
Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...
Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line ...
Mohammad Tahir Ansari, Toluwanimi Ogundipe and Callie Clark took the top three awards for presentations at the Jack Buffington Oustanding Student Poster Session in late October.
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...
About PYRUKYND® (mitapivat) PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency in the United States, and for the ...